High opioid doses, naloxone, and central nervous system active medications received by Medicare-enrolled adults.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2022
published in
has subject area
- Aged
- Aged, 80 and over
- Analgesics, Opioid
- Central Nervous System
- Central Nervous System Agents
- Cross-Sectional Studies
- Humans
- Hypnotics and Sedatives
- Medicare
- Naloxone
- Practice Patterns, Physicians'
- Retrospective Studies
- Selective Serotonin Reuptake Inhibitors
- Serotonin and Noradrenaline Reuptake Inhibitors
- United States